CIK: 1242879 - Address: 1301 2Nd Ave, Seattle, WA 98101
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret1122-123144010
P%wins1005050501005067
S%ret1115-01-11-8-36-29-14
S%wins73406767928871

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/25/11 12:06
10/21/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-1010.1033-10580D-61-71-74-72-101899-52-2238
10/19/11 13:12
10/15/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS.m-719.6533-7-1581D-67-74-77-75-1859-327-2244
8/10/11 17:19
8/9/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieM.d574.7733122588D-55-72-70-72-73-72-71-74299-3050
7/25/11 13:10
7/21/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-3938.7533-10576D601312-40-610-2-6-70-74-66
7/19/11 14:50
7/15/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS.m-28638.9833-7-1577D66223-10-4-2-7-120-66-74-64
4/25/11 19:26
4/21/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-4241.0433-10584D101211172196-206-3-4-76
4/19/11 18:56
4/15/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS.m-67941.7733-16-3585D114812132916780-1-7-5-76
3/31/11 21:01
3/29/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-3,00035.0033-86-12602D746-3-140488804179-80
9/14/10 10:43
9/10/10
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-16641.6133-4-1667D6657413723128-1-12-4-9-17-72
9/9/10 21:19
9/7/10
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS.m-1,33941.3733-32-5671D62376161325916312-8-10-22-71
9/3/10 16:25
9/2/10
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS.m-40540.5033-10-1703D5827815-117111214-230-8-20-71
9/1/10 19:03
8/30/10
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-26936.4533-7-1713D510537-1710-3-6-16108-7-13-73
8/27/10 14:08
8/25/10
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-26535.9333-7-1720D5074615-1815-8-5-3013172-7-67
8/5/10 13:23
8/4/10
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-1,56839.2133-40-5728D6036231-251323921-3-72-6-13-10
5/25/10 16:45
5/21/10
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieM.d7356.233311818762D761108543911-18-52-2-1-18-13-12-8
5/4/10 17:31
4/30/10
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS-2,15753.9333-40-6644D94015210990524341400-16-18-34-30-18
5/5/09 18:17
5/4/09
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieM.d2,5457.823332597663D16308340527393265-7-3-2161417147
5/5/09 18:17
5/4/09
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOSVP,ChieS.d-6,92721.2833-325-33663D16308340527393265-7-3-2161417147
11/28/07 12:36
11/27/07
GLGCGene Logic IncDEHealthDiagnIn Vitro & In Vivo DiagnosticUrdal DavidMDDP230.9000025New25D
6/8/06 21:44
6/8/06
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWADOSVP,ChieP204.044514810-61511598
3/18/05 21:07
3/17/05
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWAOChief ScP255.581941461D19-58-46-46-12-17-7-534-11-623-19
7/22/04 14:21
7/20/04
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsUrdal DavidWADOChief ScM.d631.42104411454D44452-22-32-16-26-15-91-4-3-9-25-32

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact